Notes - Segment Information, Etc.

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7240183

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales and profit (loss) for each reportable segment
Sales
Revenues from external customers
164,988,000,000 JPY
308,625,000,000 JPY
20,769,000,000 JPY
100,336,000,000 JPY
305,258,000,000 JPY
3,366,000,000 JPY
308,625,000,000 JPY
19,163,000,000 JPY
JPY
78,751,000,000 JPY
268,053,000,000 JPY
156,851,000,000 JPY
2,786,000,000 JPY
JPY
18,565,000,000 JPY
270,840,000,000 JPY
270,840,000,000 JPY
13,884,000,000 JPY
Transactions with other segments
3,864,000,000 JPY
JPY
1,824,000,000 JPY
5,498,000,000 JPY
11,357,000,000 JPY
85,000,000 JPY
11,442,000,000 JPY
170,000,000 JPY
-11,442,000,000 JPY
4,356,000,000 JPY
9,313,000,000 JPY
3,317,000,000 JPY
43,000,000 JPY
-9,357,000,000 JPY
1,508,000,000 JPY
JPY
9,357,000,000 JPY
130,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.